Small hairpin RNA (shRNA) and genome‐wide CRISPR‐Cas9‐based genetic screenings in melanoma cells, on the other hand, revealed ZNRF3, NF2 and ARIH1 as genes associated with cisplatin resistance [32]. This evidence concerns the gene NF2 and melanoma.